Renal effects of smoking: Potential mechanisms and perspectives

Nephrology Dialysis Transplantation

Volumn 15, Issue 7, 2000, Pages 938-940

  Halimi, Jean Michel ^a   Mimran, Albert ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYCLIC GMP; NICOTINE; NICOTINE GUM;

ARTERIAL PRESSURE; CIGARETTE SMOKING; CLINICAL TRIAL; DISEASE COURSE; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA;

EID: 0034126614     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.7.938     Document Type: Editorial

References (19)

1. Orth SR, Ritz E, Schrier RW. Renal risks of smoking. Kidney Int 1997; 51: 1669-1677
2. Stegmayr B, Lithner F. Tobacco and end-stage diabetic nephropathy. Br Med J 1987; 295: 581-582
3. Bruno G, Cavallo-Perin P, Bargero G et al. Prevalence and risk factors for micro-and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 1996; 19: 43-47
4. Chapman AB, Johnson AM, Gabow PA, Schrier RW. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 5: 1349-1354
5. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 1992; 152; 2082-2088
6. Orth SR, Stockmann A, Conradt C et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998; 54: 926-931
7. Gambaro G, Verlato F, Budakovic A et al. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol 1998; 9: 562-567
8. Ekberg G, Grefberg N, Larsson L-O, Vaara I. Cigarette smoking and glomerular filtration rate in insulin-treated diabetics without manifest nephropathy. J Intern Med 1990; 228: 211-217
9. Mimran A, Ribstein J, Du Cailar G, Halimi J-M. Albuminuria in normals and essential hypertension. J Diabetes Complications 1994; 8: 150-156
10. Cirillo M, Senigalliesi L, Laurenzi M et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking. The Gubbio population study. Arch Intern Med 1998; 158: 1933-1939
11. Mimran A, Ribstein J, Du Cailar G. Microalbuminuria in essential hypertension. Curr Opin Nephrol Hypertens 1999; 8: 359-368
12. Halimi J-M, Mimran A. Albuminuria in untreated patients with essential hypertension and primary hyperaldosteronism. J Hypertens 1995; 13: 1801-1802
13. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension. J Nephrol 1997; 10: 216-219
14. Halimi J-M, Philippon C, Mimran A. Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 1998; 13: 940-944
15. Hansen HP, Rossing K, Jacobsen P, Jensen BR, Parving HH. The acute effect of smoking on systemic hemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scand J Clin Lab Invest 1996; 56: 393-399
16. Ritz E, Benck U, Franck E, Keller C, Seyfarth M, Clorius J. Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998; 9: 1798-1804
17. Haack T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43: 267-269
18. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88 (Part 1): 2149-2155
19. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94: 6-9